Century Therapeutics appoints Conn as CFO, Cowan as CSO

Century Therapeutics announced the appointments of Morgan Conn, Ph.D., as Chief Financial Officer, CFO, and Chad Cowan, Ph.D., as Chief Scientific Officer, CSO. The appointments are effective October 14, 2024, and October 1, 2024, respectively, and both will join the Executive Committee. The Company also announced that Hy Levitsky, M.D., President of Research and Development, will be transitioning from operational duties to serve as an advisor to Century. Most recently, Conn served as Chief Business Officer at Pharvaris. Chad Cowan, Ph.D., is a pioneer in stem and cell therapy and has been serving as an executive scientific advisor at Century following the acquisition of Clade Therapeutics in April 2024, where he was founder and Chief Executive Officer.